Staffing: 2024’s Biggest Lab Operations Challenge
ADLM president Anthony Killeen looks at labs’ staffing struggles in 2024 and what can be done to alleviate them in the coming year
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
ADLM president Anthony Killeen looks at labs’ staffing struggles in 2024 and what can be done to alleviate them in the coming year
The recent FDA approval of an OTC test shows that COVID-19 saliva testing may be poised for bigger and better things in the years ahead.
Though only seven transactions were announced or closed in November, two were billion-dollar deals.
Solutions you can implement right away to address current lab staffing concerns and prepare for the future.
Increasing incidences of heart disease, as well as technological advances, will drive growth over the next eight to 10 years, reports say.
According to a recent report, digital health companies are on track to rake in $21 billion for 2022, below the 2021 total of $29.1 billion.
Continuing recent patterns, M&A deal-making in the diagnostics space was low in volume but high in impact in October.
While new test approvals were scarce in October, they were particularly impactful; here are three approvals you should know about.
The Miami-based startup has secured major in-home phlebotomy services contracts from some of the nation’s biggest lab companies.
Two lab staffing experts weigh in on current trends and what labs need to do to attract and retain talent in today’s environment.
A roundup of key mergers, acquisitions, and strategic asset purchases in the healthcare industry in September.